New Speakers Announced: Vaccines Europe Congress 2022
In anticipation of our Vaccines Europe: In-Person event happening on 29-30 November 2022 in Berlin, Germany, we look at some of the latest confirmed Industry presentations. Vaccines Europe is an intensive 2-day in-person conference that delves into the latest in vaccine research, platform technologies, analytics, and vaccine development.
A meeting place for experts working within cutting-edge vaccine research and development, presentations will delve into the different applications of vaccines in therapeutics.
- Most Anticipated Presentations: Vaccines Europe
- US Doubles its Supply of Monkeypox Vaccines
- The Future of the Vaccine: Interview with Derek O'Hagan at GlaxoSmithKline Vaccines
From antibodies against infectious diseases and T cell vaccines to adapting vaccines against new variants and developing vaccines for antimicrobial resistance pathogens, Vaccines Europe will provide a unique opportunity to gain a comprehensive understanding of the current and future vaccines landscape.
With a high-quality program devised with the help of our esteemed advisory board, some of the latest confirmed industry presentations and speakers include:
1.) ‘Rational T Cell Vaccine Design Across Therapeutic Areas’
- Induction of robust T cell responses by vaccines requires inclusion of relevant epitopes to elicit appropriate T cell activation
- An overview of prediction tools and features important for rational and optimal epitope selection in vaccine design
Monika Sekelja, Director, Head of In Silico and AI, Nykode
2.) ‘Top-Of-Mind or Forgotten – What Impact Will the Pandemic Have In The Vaccination Market?’
- A layperson could not avoid hearing about the vaccinations at the heat of the pandemic
- As the world is trying to get back to normal, where will vaccinations end up in the agenda? Top-of-mind or forgotten?
- How does the increased attention on vaccination manifests itself on regulators, public, producers and prescribers?
Ali Ciger, Country Lead for Vaccines, Pfizer
3.) ‘How To Accelerate The Supply Of Vaccines To All Populations Worldwide – Preparing For The Future’
- Understanding the regulatory complexity for vaccines and how that is amplified in a pandemic situation
- How the complexity of vaccine supply can be simplified and the ongoing work being done to address the issues
Mic McGoldrick, Associate Director Global CMC Policy, Merck Sharp & Dohme LLC
Over 300 senior attendees from leading pharmaceutical, biopharmaceutical, academics, CRO, and solution provider companies will be attending Vaccines Europe: In-Person.
Sign up for the brochure HERE and register HERE today.
For more information on Oxford Global’s Biologics 2022 event series, visit: https://oxfordglobal.com/biologics/upcoming/
